You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)
- Disease
- myocardial infarction
- Drug Name
- Brilinta
- Generic Name
- Ticagrelor
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- III
- Start Date
- Jan 18, 1971
- Study Name
- D5132C00001
- Study Id
- D5132C00001
- ClinicalTrials.gov ID
- NCT01225562
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
